Barclays initiates Harel Insurance stock with overweight rating

Published 19/06/2025, 08:54
© Shutterstock

Barclays (LON:BARC) initiated coverage on Harel Insurance Investments & Financial Services (TASE:HARL) with an overweight rating and a price target of ILs97.00 on Monday.

The research firm cited Harel’s strong execution in high-barrier-to-entry segments, noting the company has secured a 36% market share in Health and 20% in Life insurance. Harel generated a 9% CAGR in premiums and deposits from 2020 to 2024, with total premiums reaching ILS 15.4bn and 15% year-over-year growth in pension deposits in 2024, outperforming peers’ averages of ILS 10.9bn and 10% respectively.

Barclays highlighted Harel’s solvency ratio of 182% as of the first quarter of 2025, which stands well above the industry average of 157%. The firm also expressed confidence in Harel’s strategic plan, which targets ILS 1.9-2.1bn in comprehensive income and 18-19% ROE by 2026.

Currently, 82% of Harel’s operating profit comes from insurance-related segments, compared to 55% at peer Phoenix Holdings, which began diversifying several years ago. Barclays views Harel’s commitment to revenue diversification as potentially compelling given its strong balance sheet.

The research firm also pointed to Harel’s significant investments in IT and artificial intelligence as creating substantial cross-selling and up-selling opportunities for the Israeli insurance company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.